The pace of megadeals slowed this week, according to Crunchbase's tally of announced U.S. funding rounds for Oct. 10-16, 2026. Only two rounds exceeded $200 million, down from recent weeks. The largest was AI infrastructure provider Modal Labs, which raised $750 million in a Series D led by Accel at a $15.75 billion valuation. The company says it recently passed a $1 billion annual revenue run rate.
The second-largest round went to Icon, an Austin-based construction robotics company known for 3D-printed homes, which closed $200 million in Series D funding led by Baillie Gifford and BlackRock. Icon says it is on pace for 4x revenue growth in 2026.
Other notable rounds included RNA therapy developer Soufflé Therapeutics ($135M Series B), gene therapy startup Estuary Biotherapeutics ($103M), and AI training platform Labelbox ($100M Series E). Health AI company Suki raised $90M, caregiver platform Abby Care raised $82M, and insurance startup Stand raised $70M at a $1B valuation. Semiconductor firm Mueon and AI spend management company North.cloud rounded out the top 10 with $65M and $60M, respectively.